FR2321899A1 - Vaccins bivalents contre la rubeole et la cytomegalie - Google Patents

Vaccins bivalents contre la rubeole et la cytomegalie

Info

Publication number
FR2321899A1
FR2321899A1 FR7624951A FR7624951A FR2321899A1 FR 2321899 A1 FR2321899 A1 FR 2321899A1 FR 7624951 A FR7624951 A FR 7624951A FR 7624951 A FR7624951 A FR 7624951A FR 2321899 A1 FR2321899 A1 FR 2321899A1
Authority
FR
France
Prior art keywords
strain
rubella
cytomegaly
attenuated
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7624951A
Other languages
English (en)
French (fr)
Other versions
FR2321899B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RIT RECH IND THERAPEUT
Original Assignee
RIT RECH IND THERAPEUT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from BE159475A external-priority patent/BE832758A/fr
Application filed by RIT RECH IND THERAPEUT filed Critical RIT RECH IND THERAPEUT
Publication of FR2321899A1 publication Critical patent/FR2321899A1/fr
Application granted granted Critical
Publication of FR2321899B1 publication Critical patent/FR2321899B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36211—Rubivirus, e.g. rubella virus
    • C12N2770/36234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR7624951A 1975-08-26 1976-08-17 Vaccins bivalents contre la rubeole et la cytomegalie Granted FR2321899A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE159475A BE832758A (fr) 1975-08-26 1975-08-26 Vaccins bivalents contre la rubeole et la cytomegalie

Publications (2)

Publication Number Publication Date
FR2321899A1 true FR2321899A1 (fr) 1977-03-25
FR2321899B1 FR2321899B1 (enExample) 1978-12-22

Family

ID=3842805

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7624951A Granted FR2321899A1 (fr) 1975-08-26 1976-08-17 Vaccins bivalents contre la rubeole et la cytomegalie

Country Status (1)

Country Link
FR (1) FR2321899A1 (enExample)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Also Published As

Publication number Publication date
FR2321899B1 (enExample) 1978-12-22

Similar Documents

Publication Publication Date Title
Wiktor Cell-mediated immunity and postexposure protection from rabies by inactivated vaccines of tissue culture origin
FR2344629A1 (fr) Procede pour la purification et l'isolement de virus de l'hepatite utilisable pour la preparation d'un vaccin
IT7829570A0 (it) Metallo-ceramico realizzato articolo resistente al fuoco, mediante titanato di alluminio nonche' corpo composito contente del silicato.
EP0270317A3 (en) Pharmaceutical compositions for the treatment of diseases caused by viruses
DE3174807D1 (en) Pharmaceutical composition
BR8000514A (pt) Processo de operar um sistema de refrigeracao por compressao de vapor, e, respectivo sistema de refrigeracao
DE3266294D1 (en) Method for the preparation of antigens of the viral hepatitis nanb, and application to the preparation of a reaction agent allowing the diagnosis and prognosis of infections caused by the viruses of viral hepatitis
DE3885431D1 (de) Expression der viral kodierten Protease P2A des HRV2.
PT84155A (en) Method of modifying plant viruses or their effects
ATE79548T1 (de) Herpes simplex virus subunitimpfstoff.
IT7822442A0 (it) Procedimento per la preparazione di un ceppo virale di gastroenterite trasmissibile attenuato da applicare a vaccini vivi.
ES8504459A1 (es) Procedimiento para preparar factor de transferencia especifico a un virus determinado.
EP0616535A4 (en) PROCESS FOR THE TREATMENT OF VIRAL INFECTIONS.
ZA813479B (en) Process for the isolation of viral glycoproteic antigens and its application to the preparation of vaccines
FI890116A0 (fi) Icke-reverterande rna-virus.
NO880935D0 (no) Fremgangmsaate for paavisning av hiv eller annet virus med lignende klinisk virkning.
ES8704962A1 (es) Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida.
FR1335564A (fr) Four cloche pour la préparation de l'uranium par magnésiothermie
DK111632C (da) Apparat til behandling af bronchiektasis og andre sygdomstilstande, hvor der findes væske eller slim i patientens luftveje.
DE2966648D1 (en) Vaccine against diseases caused by reo viruses, combined vaccine with newcastle disease virus, process for preparing them and reo virus strain used for their preparation
ES379634A1 (es) Procedimiento de fabricacion de productos vitroceramicos.
DE69428112D1 (de) Verwendung von thymosin zur behandlung von hepatitis c bei patienten, die auf interferongaben nicht ansprechen
EP0316592A3 (en) 3'-fluoro-2',3'-dideoxyuridine, and its therapeutic application
JPS51118825A (en) A process for preparing heat stable iga and igm
NZ507942A (en) Viral chimeras comprised of CAEV and HIV-1 genetic elements

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse